Vaccines and Antibody-Based Therapeutics Against Infectious Disease
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 788
Special Issue Editor
Interests: infectious disease; host immune response; vaccine and diagnostics development; targeting cellular signal molecules; transcription factors; immune regulation and immunotherapeutics
Special Issue Information
Dear Colleagues,
Infectious diseases remain a global challenge due to their continual resurgence and persistence, impacting humans and agriculture. It is important to prevent these diseases and epidemics. Although there have been recent advances in preventive therapeutics, there is still a need to develop vaccines and antibody-based therapeutic disease interventions. New approaches are needed, whether prophylactic or therapeutic, to advance the field and achieve better outcomes.
This Special Issue aims to update advances in vaccine and antibody-based therapies. The collection will address current research and the development of new technologies and welcomes review and original research articles focusing on new horizons of immunity and therapy against infectious diseases that emphasize preclinical and clinical vaccines, antibody-based prophylaxis, and treatment regimens.
Dr. Suman Kundu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious disease
- vaccine
- antibody
- therapy
- agriculture
- protection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
